Whitfield Bryson & Mason LLP has been a leader in defective pharmaceuticals litigation for many years. We have the experience, drive, and resources to help you receive the compensation you deserve.
Taxotere is a drug that was prescribed to breast cancer patients as a chemotherapy treatment. It is believed that the manufacturer of Taxotere knew there was a risk of permanent hair loss or baldness for patients, yet failed to warn patients of this serious risk. This failure to warn deprived patients of a meaningful choice of whether or not to take the risk of permanent hair loss with Taxotere.
If you or someone you know has experienced either permanent hair loss or baldness after undergoing chemotherapy and using Taxotere, you may be entitled to compensation.